Culture conversion rates of multi-drug resistant (MDR-TB) patients treated in the community versus an inpatient setting in a rural area of the Western Cape (WC) of South Africa

M. Van der Walt, K. Shean, D. Upadhya, S. Siwendu (Pretoria, South Africa; Philidelphia, United States Of America)

Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment
Session: Pros and cons of MDR- and XDR-TB treatment
Session type: Oral Presentation
Number: 4288
Disease area: Respiratory infections

Congress or journal article abstractSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Van der Walt, K. Shean, D. Upadhya, S. Siwendu (Pretoria, South Africa; Philidelphia, United States Of America). Culture conversion rates of multi-drug resistant (MDR-TB) patients treated in the community versus an inpatient setting in a rural area of the Western Cape (WC) of South Africa. Eur Respir J 2012; 40: Suppl. 56, 4288

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Death rates in patients during and after MDR-TB treatment in a semi rural area of South Africa
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011

Prognosis and outcome in patients with extremely drug resistant tuberculosis from the Western Cape province, South Africa
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008

Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible?
Source: Eur Respir J, 50 (2) 1700753; 10.1183/13993003.00753-2017
Year: 2017



Number of tuberculosis (TB) cases reported by primary care physicians (PCPs) in India: Results of a 1-day point prevalence study in 880 urban cities and towns in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Traditional healers, treatment delay, performance status and death from tuberculosis in rural South Africa
Source: Eur Respir J 2005; 26: Suppl. 49, 428s
Year: 2005

Performance outcomes of a standardized LAM antigen-detected test in TB suspects recruited in Cape Town, South Africa
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008

Tuberculosis (TB) out-patient clinic in a low prevalence country: a 5-year experience of a Northern Italian city
Source: Eur Respir J 2004; 24: Suppl. 48, 415s
Year: 2004

Resistance of Mycobacterium tuberculosis to the first-line (MDR) and second line (XDR) anti tuberculosis drugs in the south western zone of Nigeria: A- 3 year retrospective study
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Comparison of hospital-checked, directly observed therapy with family supervised and unchecked tuberculosis treatment in a rural setting in North India
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002

A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate?
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Prevalence and characteristic of drug-resistant tuberculosis patients in South Halmahera District, eastern Indonesia
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


The use of antibiotics in primary care: a cross-sectional survey of a rural city in South Turkey
Source: Eur Respir J 2007; 30: Suppl. 51, 124s
Year: 2007

Which patients are (not) able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey
Source: Eur Respir J 2005; 26: Suppl. 49, 428s
Year: 2005

A retrospective analysis of quinolone prescriptions for tuberculosis in two North Birmingham hospitals
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Dynamics of MBT drug resistance in a specialized urban TB hospital (Saratov, Russia)
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012


Aspects of effective MDR-TB treatment in the prison hospital, Tomsk (Russia)
Source: Eur Respir J 2006; 28: Suppl. 50, 17s
Year: 2006

Prevalence of pneumonia reported by primary care physicians (PCPs) in India: Results of a 1-day point prevalence study in 880 urban cities and towns in India
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Incidence of latent tuberculosis infection(LTBI) among high risk healthcare workers at a tertiary referral hospital in South Korea.
Source: International Congress 2017 – Migrants and screening
Year: 2017